市场调查报告书
商品编码
1308518
壳聚糖市场:2023-2028年全球行业趋势、份额、规模、增长、机会及预测Chitosan Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年,全球壳聚糖市场规模达到23亿美元。展望未来,IMARC集团预计到2028年全球甲壳素市场规模将达到46亿美元,2023-2028年的复合年增长率(CAGR)将达到12.3%。
壳聚糖是从虾、蟹、龙虾以及蘑菇和酵母的硬壳中提取的天然脱乙酰甲壳素。它主要用作治疗各种疾病的药物成分,如肾衰竭、肥胖、贫血、高胆固醇水平、高磷血症、失眠和克罗恩病。在医药制造领域,壳聚糖可用于开发可食用薄膜、片剂填料、控释药物载体以及改善某些药物盐类的溶解性。壳聚糖具有抗菌和抗真菌特性,在化妆品、农业和食品工业中被广泛用作天然抗菌剂。
医药行业的不断发展以及全球对废水处理要求的不断提高是推动市场增长的关键因素。在制药行业,壳聚糖作为一种具有抗菌和抑菌特性的生物材料,在生产生物医学和组织再生设备、血液透析膜以及药物输送系统的植入涂层方面的需求日益增长。此外,水处理厂对该材料的需求也在增加,以去除工业、市政和商业废物中的杂质,包括重金属、磷和油类。它还可用作絮凝剂、凝结剂和螯合剂,这也是一个主要的增长诱因。此外,由于其无毒性,壳聚糖正越来越多地被用作食品添加剂和膳食补充剂。促进市场增长的其他因素包括旨在改善地表水、地下水和饮用水质量的各种政府政策,以及加强从非水生来源开发壳聚糖的研发工作。
The global chitosan market size reached US$ 2.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.6 Billion by 2028, exhibiting a growth rate (CAGR) of 12.3% during 2023-2028.
Chitosan is a naturally occurring deacetylated chitin which is extracted from the hard outer-skeleton or shells of shrimps, crabs and lobsters, along with mushrooms and yeasts. It is primarily used as an ingredient in medicines for treating various conditions, such as kidney failure, obesity, anemia, high cholesterol levels, hyperphosphatemia, insomnia and Crohn's disease. In the pharmaceutical manufacturing sector, chitosan is utilized in the development of edible films; as a filler in tablets; a carrier in controlled-release drugs and to improve the dissolvability of certain medicinal salts. Having antibacterial and antifungal properties, chitosan is extensively used as a natural antimicrobial agent in the cosmetics, agricultural and food industries.
The growing pharmaceutical industry, along with the increasing requirement for wastewater treatment across the globe represent the key factors driving the growth of the market. In the pharmaceutical industry, chitosan being a biomaterial with antibacterial and antimicrobial properties is gaining demand in the production of biomedical and tissue regeneration devices, hemodialysis membranes, and implant coatings for drug delivery systems. Furthermore, its demand is also increasing in the water treatment plants for eliminating impurities present in the industrial, municipal, and commercial waste, including heavy minerals, phosphorous and oils. It is also used as a flocculating, coagulating, and chelating agent, which is further acting as a major growth-inducing factor. Additionally, owing to its non-toxic nature, chitosan is increasingly being adopted as a food additive and dietary supplement. Other factors contributing to the market growth include various government policies aimed to improve the quality of surface, ground and drinking water, coupled with the enhanced research and development (R&D) to develop chitosan from non-aquatic sources.
IMARC Group provides an analysis of the key trends in each sub-segment of the global chitosan market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on grade, source and application.
Industrial Grade
Food Grade
Pharmaceutical Grade
Shrimp
Crab
Squid
Krill
Others
Water Treatment
Food & Beverages
Cosmetics
Medical & Pharmaceuticals
Agrochemicals
Others
Asia Pacific
Europe
North America
Middle East and Africa
Latin America
The report has also analysed the competitive landscape of the market with some of the key players being Primex EHF, Heppe Medical Chitosan GmbH, Meron Group, KitoZyme SA, Golden-Shell Pharmaceutical Co. Ltd., FMC Corporation, Agra Tech, Inc., Axio Biosolutions Pvt Ltd and Marshall Marine Products.